184 related articles for article (PubMed ID: 25514669)
1. [Changes in prescription patterns to patients with bipolar syndromes. Increased use of lamotrigine and decreased use of lithium].
Karanti A; Kardell M; Lundberg U; Landén M
Lakartidningen; 2014 Dec; 111(51-52):2284-6. PubMed ID: 25514669
[TBL] [Abstract][Full Text] [Related]
2. Changes in mood stabilizer prescription patterns in bipolar disorder.
Karanti A; Kardell M; Lundberg U; Landén M
J Affect Disord; 2016 May; 195():50-6. PubMed ID: 26859073
[TBL] [Abstract][Full Text] [Related]
3. The use of lithium, valproate or lamotrigine for psychiatric conditions in children and adolescents in Norway 2004-2007 - a prescription database study.
Bramness JG; Grøholt B; Engeland A; Furu K
J Affect Disord; 2009 Oct; 117(3):208-11. PubMed ID: 19189871
[TBL] [Abstract][Full Text] [Related]
4. Gender differences in the treatment of patients with bipolar disorder: a study of 7354 patients.
Karanti A; Bobeck C; Osterman M; Kardell M; Tidemalm D; Runeson B; Lichtenstein P; Landén M
J Affect Disord; 2015 Mar; 174():303-9. PubMed ID: 25532077
[TBL] [Abstract][Full Text] [Related]
5. Nationwide and population-based prescription patterns in bipolar disorder.
Kessing LV; Vradi E; Andersen PK
Bipolar Disord; 2016 Mar; 18(2):174-82. PubMed ID: 26890465
[TBL] [Abstract][Full Text] [Related]
6. [Guidelines for the prescription of mood stabilizers for adolescents: A literature review].
Munch G; Godart N
Encephale; 2017 Oct; 43(5):464-470. PubMed ID: 27871720
[TBL] [Abstract][Full Text] [Related]
7. A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder.
Bowden CL; Calabrese JR; Sachs G; Yatham LN; Asghar SA; Hompland M; Montgomery P; Earl N; Smoot TM; DeVeaugh-Geiss J;
Arch Gen Psychiatry; 2003 Apr; 60(4):392-400. PubMed ID: 12695317
[TBL] [Abstract][Full Text] [Related]
8. The pattern of pharmacological treatment of bipolar patients discharged from psychiatric units in Poland.
Jaracz J; Rudnicka ET; Bierejszyk M; Witczyk K; Raczyńska A; Nowak W; Pisarczyk A; Woźniak K; Czernaś W; Moniakowski A; Jaracz K
Pharmacol Rep; 2018 Aug; 70(4):694-698. PubMed ID: 29933206
[TBL] [Abstract][Full Text] [Related]
9. Impact of lamotrigine and lithium on weight in obese and nonobese patients with bipolar I disorder.
Bowden CL; Calabrese JR; Ketter TA; Sachs GS; White RL; Thompson TR
Am J Psychiatry; 2006 Jul; 163(7):1199-201. PubMed ID: 16816224
[TBL] [Abstract][Full Text] [Related]
10. An observational nationwide register based cohort study on lamotrigine versus lithium in bipolar disorder.
Kessing LV; Hellmund G; Andersen PK
J Psychopharmacol; 2012 May; 26(5):644-52. PubMed ID: 21948935
[TBL] [Abstract][Full Text] [Related]
11. Substantial changes in prescription recommendations for bipolar disorder in Canada: 2002-2010.
Bulloch AG; Bresee LC; Beck CA; Patten SB
Can J Psychiatry; 2012 Apr; 57(4):263-8. PubMed ID: 22480592
[TBL] [Abstract][Full Text] [Related]
12. Lamotrigine compared to placebo and other agents with antidepressant activity in patients with unipolar and bipolar depression: a comprehensive meta-analysis of efficacy and safety outcomes in short-term trials.
Solmi M; Veronese N; Zaninotto L; van der Loos ML; Gao K; Schaffer A; Reis C; Normann C; Anghelescu IG; Correll CU
CNS Spectr; 2016 Oct; 21(5):403-418. PubMed ID: 27686028
[TBL] [Abstract][Full Text] [Related]
13. [The treatment of mood stabilizers in children and adolescents suffering from bipolar affective disorder].
Green T; Shoval G; Weizman A
Harefuah; 2005 Nov; 144(11):810-5, 821. PubMed ID: 16358659
[TBL] [Abstract][Full Text] [Related]
14. International prescribing patterns for mood illness: the International Mood Network (IMN).
Mauer S; Alahmari R; Vöhringer PA; Vergne DE; Lövdahl H; Correa E; Patkar A; Pae C; Strejilevich S; Dalley S; Ghaemi SN
J Affect Disord; 2014; 167():136-9. PubMed ID: 24955565
[TBL] [Abstract][Full Text] [Related]
15. Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: consensus and controversies.
Yatham LN; Kennedy SH; O'Donovan C; Parikh S; MacQueen G; McIntyre R; Sharma V; Silverstone P; Alda M; Baruch P; Beaulieu S; Daigneault A; Milev R; Young LT; Ravindran A; Schaffer A; Connolly M; Gorman CP;
Bipolar Disord; 2005; 7 Suppl 3():5-69. PubMed ID: 15952957
[TBL] [Abstract][Full Text] [Related]
16. Utilization of Antiepileptic Medicines in Swedish Children and Adolescents with Different Diagnoses.
Karlsson Lind L; Wide K; Wettermark B; von Euler M
Basic Clin Pharmacol Toxicol; 2018 Jul; 123(1):94-100. PubMed ID: 29427409
[TBL] [Abstract][Full Text] [Related]
17. Patterns of psychotropic drug prescription for U.S. patients with diagnoses of bipolar disorders.
Baldessarini RJ; Leahy L; Arcona S; Gause D; Zhang W; Hennen J
Psychiatr Serv; 2007 Jan; 58(1):85-91. PubMed ID: 17215417
[TBL] [Abstract][Full Text] [Related]
18. 20-Year Trends in the Pharmacologic Treatment of Bipolar Disorder by Psychiatrists in Outpatient Care Settings.
Rhee TG; Olfson M; Nierenberg AA; Wilkinson ST
Am J Psychiatry; 2020 Aug; 177(8):706-715. PubMed ID: 32312111
[TBL] [Abstract][Full Text] [Related]
19. Antidepressant effects of lamotrigine in rapid cycling bipolar disorder.
Calabrese JR; Fatemi SH; Woyshville MJ
Am J Psychiatry; 1996 Sep; 153(9):1236. PubMed ID: 8780440
[No Abstract] [Full Text] [Related]
20. Pharmacological Treatment Patterns at Study Entry for the First 500 STEP-BD Participants.
Ghaemi SN; Hsu DJ; Thase ME; Wisniewski SR; Nierenberg AA; Miyahara S; Sachs G
Psychiatr Serv; 2006 May; 57(5):660-5. PubMed ID: 16675760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
